Vienna - Delayed Quote EUR

ResMed Inc. (RMD.VI)

Compare
237.70
+3.00
+(1.28%)
As of 11:00 AM GMT+1. Market Open.
Loading Chart for RMD.VI
DELL
  • Previous Close 234.70
  • Open 238.20
  • Bid 235.30 x --
  • Ask 239.90 x --
  • Day's Range 237.70 - 238.20
  • 52 Week Range 139.70 - 239.00
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 35.407B
  • Beta (5Y Monthly) 0.69
  • PE Ratio (TTM) 32.88
  • EPS (TTM) 7.23
  • Earnings Date Jan 22, 2025 - Jan 27, 2025
  • Forward Dividend & Yield 1.98 (0.84%)
  • Ex-Dividend Date Nov 7, 2024
  • 1y Target Est --

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

www.resmed.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: RMD.VI

View More

Performance Overview: RMD.VI

Trailing total returns as of 11/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RMD.VI
54.06%
S&P 500
25.53%

1-Year Return

RMD.VI
70.89%
S&P 500
31.32%

3-Year Return

RMD.VI
7.78%
S&P 500
27.35%

5-Year Return

RMD.VI
85.90%
S&P 500
91.07%

Compare To: RMD.VI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RMD.VI

View More

Valuation Measures

Annual
As of 11/25/2024
  • Market Cap

    34.96B

  • Enterprise Value

    35.36B

  • Trailing P/E

    32.43

  • Forward P/E

    26.74

  • PEG Ratio (5yr expected)

    1.86

  • Price/Sales (ttm)

    7.51

  • Price/Book (mrq)

    6.91

  • Enterprise Value/Revenue

    7.71

  • Enterprise Value/EBITDA

    22.80

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    23.15%

  • Return on Assets (ttm)

    13.27%

  • Return on Equity (ttm)

    23.57%

  • Revenue (ttm)

    4.81B

  • Net Income Avi to Common (ttm)

    1.11B

  • Diluted EPS (ttm)

    7.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    442.58M

  • Total Debt/Equity (mrq)

    16.37%

  • Levered Free Cash Flow (ttm)

    1.12B

Research Analysis: RMD.VI

View More

Company Insights: RMD.VI

Research Reports: RMD.VI

View More

People Also Watch